CD274 and cancer: Since the discovery and understanding of Programmed Cell Death 1 (PD-1)/Programmed Cell Death Ligand 1 (PD-L1) interactions between cancer and immune cells, blocking the PD-1/PD-L1 interaction has become a novel therapeutic strategy in cancer treatment.